Serveur d'exploration Tocilizumab - Curation (Pmc)

Index « Auteurs » - entrée « Masaki Katayama »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Masakatsu Yanagimachi < Masaki Katayama < Masaki Shimizu  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000148 (2019) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study
000214 (2019) Wataru Fukuda ; Tadamasa Hanyu ; Masaki Katayama ; Shinichi Mizuki ; Akitomo Okada ; Masayuki Miyata ; Yuichi Handa ; Masatoshi Hayashi ; Yoshinobu Koyama ; Kaoru Arii ; Toshiyuki Kitaori ; Hiroyuki Hagiyama ; Yoshinori Urushidani ; Takahito Yamasaki ; Yoshihiko Ikeno ; Takeshi Suzuki ; Atsushi Omoto ; Toshifumi Sugitani ; Satoshi Morita ; Shigeko InokumaRisk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital
000C92 (2019) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Pmc/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/Author.i -k "Masaki Katayama" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/Author.i  \
                -Sk "Masaki Katayama" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Pmc
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Masaki Katayama
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021